Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine
This study has been completed.
Study NCT00167739   Information provided by Albert Schweitzer Hospital
First Received: September 11, 2005   Last Updated: September 19, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
Additional conditions recognized in this trial
Malaria, Falciparum
More general conditions related to this trial
Coccidiosis
Parasitic Diseases
Protozoan Infections
Additional drug interventions recognized in this trial
Pyrimethamine
Quinine
Sulfadoxine
Sulfadoxine-pyrimethamine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Central Nervous System Agents
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Albert Schweitzer Hospital
Medical Research Unit, Lambaréné


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services